Prosecution Insights
Last updated: May 29, 2026

Neuboron Therapy System Ltd.

3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days

Portfolio Summary

3
Total Pending OAs
2
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
3
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only3 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
3
Semiconductors
100% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

30 h
Manual time on pending OAs
6 h
Time saved (low, 20%)
10 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KALISZEWSKI, ALINA ROSE 1 83.0% +24.3%
OSENBAUGH-STEWART, ELIZA W 1 73.4% +16.6%
CHANG, HANWAY 1 85.8% +8.5%

Quick Wins (2)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18230260 NEUTRON-CAPTURE THERAPY SYSTEM KALISZEWSKI, ALINA ROSE 17d overdue
18099316 RADIOTHERAPY SYSTEM AND METHOD FOR CONTROLLING SAFETY INTERLOCK THEREOF CHANG, HANWAY

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18109988 RADIOACTIVE RAY RADIATION SYSTEM AND CONTROL METHOD THEREFOR OSENBAUGH-STEWART, ELIZA W 72d overdue
18230260 NEUTRON-CAPTURE THERAPY SYSTEM KALISZEWSKI, ALINA ROSE 17d overdue

Top Art Units

Art UnitApps
2881 2
2878 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18230260 NEUTRON-CAPTURE THERAPY SYSTEM KALISZEWSKI, ALINA ROSE 2881 §103 Non-Final OA 17d overdue Pending Aug 04, 2023
18109988 RADIOACTIVE RAY RADIATION SYSTEM AND CONTROL METHOD THEREFOR OSENBAUGH-STEWART, ELIZA W 2881 §103 Final Rejection 72d overdue Pending Feb 15, 2023
18099316 RADIOTHERAPY SYSTEM AND METHOD FOR CONTROLLING SAFETY INTERLOCK THEREOF CHANG, HANWAY 2878 §103 Non-Final OA Pending Jan 20, 2023

Managing Neuboron Therapy System Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month